SKYE · Skye Bioscience, Inc.
$0.61
-0.01 (-1.45%)
At close · Jul 29
Going-concern doubt
— flagged May 11, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These conditions give rise to substantial doubt as to the Company's ability to continue as a going concern within one year after the date that these financial statements are issued. After considering the plans to alleviate substantial doubt, management has concluded that there is substantial doubt about the Company's ability to continue as a going concern within one year after the date that these financial statements are issued.”View the 10-Q filed May 11, 2026
Market Cap
$21.61M
Shares
35.14M
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2024-11-15 | DHILLON PUNIT | Officer, Director | 100,693 | 2024-11-15 | Piper Sandler & Co Inc |
| 2024-11-15 | Diep Tuan Tu | Officer | 22,877 | 2024-11-15 | Piper Sandler & Co Inc |
| 2024-11-15 | Grayson Paul A. | Director | 86,804 | 2024-11-15 | Piper Sandler & Co Inc |
| 2024-11-15 | ARSENAULT KAITLYN | Officer | 57,084 | 2024-11-15 | Piper Sandler & Co Inc |
Showing 1–4 of 4 filings